David Ryan Ormond - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by David Ryan Ormond

This paper is made freely available by the publisher.

2023 Sarthak Pati

ORCID

ORCID

, Brandon Edwards

ORCID

, Micah Sheller, Shih-Han Wang, G. Anthony Reina, G. Anthony Reina, Patrick Foley

ORCID

, Alexey Gruzdev, Deepthi Karkada

ORCID

, Christos Davatzikos

ORCID

ORCID

, Satyam Ghodasara

ORCID

, Michel Bilello, Suyash Mohan

ORCID

and 273 other authors

Author Correction: Federated learning enables big data for rare cancer boundary detection

Download from www.nature.com

This paper is made freely available by the publisher.

Trang H. Au

ORCID

, Connor Willis

ORCID

ORCID

, Katherine B. Peters

ORCID

, Phioanh Leia Nghiemphu

ORCID

, Jennie W. Taylor

ORCID

, Howard Colman

ORCID

, Adam L. Cohen, David Ryan Ormond

ORCID

, Elizabeth C. Neil, Arnab Chakravarti, Nicole Willmarth, Bea Christine Balajonda, Jyothi Menon, Junjie Ma and 8 other authors

Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study

Download from doi.org

This paper is made freely available by the publisher.

2022 Wenbo Zhou, Daniel Lovasz

ORCID

ORCID

, Qianbin He, Christina Coughlan, Robert Kowalski, Peter Kennedy

ORCID

, Arin Graner, Kevin Lillehei, D. Ormond

ORCID

, A. Youssef, Michael Graner

ORCID

ORCID

Phenotype and Neuronal Cytotoxic Function of Glioblastoma Extracellular Vesicles

Download from doi.org

Distributing this paper is prohibited by the publisher

Philip D. Tatman, Tadeusz H. Wroblewski, Anthony R. Fringuello, Samuel R. Scherer, William B. Foreman, Denise M. Damek, A. Samy Youssef, Kevin O. Lillehei, Randy L. Jensen, Michael W. Graner

ORCID

, D. Ryan Ormond

ORCID

High-Throughput Screening of Epigenetic Inhibitors in Meningiomas Identifies HDAC, G9a, and Jumonji-Domain Inhibition as Potential Therapies

Upload

This paper was not found in any repository, but could be made available legally by the author.

Philip D. Tatman, Tadeusz H. Wroblewski

ORCID

, Anthony R. Fringuello, Samuel R. Scherer

ORCID

, William B. Foreman

ORCID

, Denise M. Damek, Kevin O. Lillehei

ORCID

, Randy L. Jensen

ORCID

, A. Samy Youssef, D. Ryan Ormond

ORCID

, Michael W. Graner

ORCID

Targeting DNA Methyl Transferases with Decitabine in Cultured Meningiomas

Upload

This paper was not found in any repository, but could be made available legally by the author.

Frederick S. Varn, Pieter Wesseling, Taylor E. Wade, Thais S. Sabedot, Adelheid Wöehrer

ORCID

, Santhosh K. Sivajothi, Kevin C. Johnson, Kieron White, Jan Martinek, Steven Pollock, Jason T. Huse, MacLean P. Nasrallah, Lee A. D. Cooper, Tathiane M. Malta, D. Ryan Ormond

ORCID

and 86 other authors

Glioma progression is shaped by genetic evolution and microenvironment interactions

Upload

This paper is made freely available by the publisher.

Isabelle M. Germano

ORCID

, Mateo Ziu, Patrick Wen, D. Ryan Ormond

ORCID

, Jeffrey J. Olson

Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults

Download from link.springer.com

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Philip D. Tatman, Tadeusz Wroblewski, Anthony Fringurello, Sam Scherer, Will Foreman, Denise Damek, Kevin Lillehei, Samy Youssef, Ryan Ormond

ORCID

, Michael Graner

High-Throughput Screening of FDA-Approved Compounds, Validated with Three Separate Xenograft Models, Identifies Brigatinib as a Potential Treatment for Recurrent and Metastatic Chordomas

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Tadeusz H. Wroblewski, Philip D. Tatman, Anthony R. Fringuello, Samuel S. Scherer, William B. Foreman, Denise M. Damek, Kevin Lillehei, Randy L. Jensen, A. Samy Youssef, D. R. Ormond

ORCID

, Michael W. Graner

DNA Methyl Transferase Inhibition in Meningiomas

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Philip Tatman, Tadeusz Wroblewski, Anthony Fringurello, Sam Scherer, William Foreman, Denise Damek, Samy Youssef, Randy Jensen, Kevin Lillehei, Ryan Ormond

ORCID

, Michaerl Graner

High-Throughput Screening of Epigenetic Inhibitors in Meningiomas Identifies Sensitivities toward HDAC, G9A, and Jumonji Domain Inhibition

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Tadeusz H. Wroblewski, Philip D. Tatman, Anthony R. Fringuello, Samuel R. Scherer, William B. Foreman, Denise M. Damek, Kevin Lillehei, Randy L. Jenson, A. Samy Youssef, D. Ryan Ormond

ORCID

, Michael W. Graner

High-Throughput Screening of Meningiomas Identifies Proteasome Inhibition as a Potential Treatment Avenue

Upload

This paper is made freely available by the publisher.

Sarthak Pati

ORCID

ORCID

, Brandon Edwards

ORCID

, G. Anthony Reina, Micah Sheller, Shih-Han Wang, G. Anthony Reina, Patrick Foley

ORCID

, Alexey Gruzdev, Deepthi Karkada

ORCID

, Christos Davatzikos

ORCID

ORCID

, Satyam Ghodasara

ORCID

, Michel Bilello, Suyash Mohan

ORCID

and 271 other authors

Federated Learning Enables Big Data for Rare Cancer Boundary Detection

Download from doi.org

This paper is made freely available by the publisher.

2021 Philip Tatman, Tadeusz Wroblewski, Anthony Fringuello, Sam Scherer, William Foreman, Denise Damek, Samy Youssef, Kevin Lillehei, David Ormond

ORCID

, Michael Graner

Ddre-43. Screening of Fda-Approved Compounds for the Treatment of Chordoma, With in Vivo Validation Using Three Different Xenograft Models, Identifies Brigatinib as a Potential Treatment

Download from academic.oup.com

This paper is made freely available by the publisher.

Tadeusz Wroblewski, Philip Tatman, Anthony Fringuello, Sam Scherer, William Foreman, Denise Damek, Samy Youssef, Kevin Lillehei, David Ormond

ORCID

, Michael Graner

Ddre-45. High-Throughput Screening of Epigenetic Compounds for the Treatment of Chordoma Identifies Potential Novel Therapeutics

Download from academic.oup.com

This paper is made freely available by the publisher.

Tadeusz Wroblewski, Philip Tatman, Anthony Fringuello, Sam Scherer, William Foreman, Denise Damek, Samy Youssef, Kevin Lillehei, David Ormond

ORCID

, Michael Graner

Ddre-20. High-Throughput Screening of Fda-Approved Compounds in Glioma and Glioblastoma Identifies Novel Therapeutics

Download from academic.oup.com

This paper is made freely available by the publisher.

Frederick Varn, Kevin Johnson, Taylor Wade, Tathiane Malta, Thais Sabedot, Floris Barthel, Hoon Kim, Nazia Ahmed, Indrani Datta, Jill Barnholtz-Sloan, Spyridon Bakas, Fulvio D'Angelo, Hui Gan, Luciano Garofano, Jason Huse and 16 other authors

Epco-09. Longitudinal Analysis of Diffuse Glioma Reveals Cell State Dynamics at Recurrence Associated With Changes in Genetics and the Microenvironment

Download from academic.oup.com

This paper is made freely available by the publisher.

Evan Winograd, Isabelle Germano, Patrick Wen, Jeffrey J. Olson, D. Ryan Ormond

ORCID

Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of targeted therapies and immunotherapies in the management of progressive glioblastoma

Download from link.springer.com

This paper is made freely available by the publisher.

Kareem R. Fakhoury, Douglas E. Ney, D. Ryan Ormond

ORCID

, Chad G. Rusthoven

Immunotherapy and radiation for high-grade glioma: a narrative review

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2020 Dominic Harris, David R. Ormond

ORCID

, Kristopher T. Kimmell

CMS Patient Satisfaction Metrics Do Not Correlate with Patient Safety Measures

Upload

This paper was not found in any repository, but could be made available legally by the author.

Katherine Belanger, Timothy H. Ung, Douglas Ney, Kevin O. Lillehei, Chad Rusthoven, Denise M. Damek, David R. Ormond

ORCID

Concomitant Temozolomide Plus Radiotherapy Demonstrates Favorable Progression Free Survival in Recurrent Meningioma

Upload

Missing publications? Search for publications with a matching author name.